A SOLID PHARMACEUTICAL COMPOSITION CONTAINING 2-ETHOXY-1-{ [2-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL) BIPHENYL-4-YL]METHYL}-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID OR A SALT THEREOF, A FAT AND OIL-LIKE SUBSTACE HAVING LOW MELTING POINT AND A LOW VISCOSITY BINDER
THE PRESENT INVENTION PROVIDES A SOLID PHARMACEUTICAL COMPOSITION SUPERIOR IN THE STABILITY AND DISSOLUTION PROPERTY, WHEREIN THE DRUG DISSOLUTION PROPERTY OF A SOLID DOSAGE FORM CONTAINING A FAT AND OIL-LIKE SUBSTANCE HAVING A LOW MELTING POINT IS IMPROVED. THE PRESENT INVENTION PROVIDES A SOLID PHARMACEUTICAL COMPOSITION CONTAINING AN ACTIVE INGREDIENT, A FAT AND OIL- LIKE SUBSTANCE HAVING A LOW MELTING POINT AND A LOW VISCOSITY BINDER, AND A METHOD OF IMPROVING DISSOLUTION OF AN ACTIVE INGREDIENT FROM A SOLID PHARMACEUTICAL COMPOSITION CONTAINING THE ACTIVE INGREDIENT AND A FAT AND OIL-LIKE SUBSTANCE HAVING A LOW MELTING POINT, WHICH INCLUDES USING A LOW VISCOSITY BINDER. FIG. 1
